{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:35:17Z","timestamp":1791401717175,"version":"4.3.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41590-026-02582-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:03:19Z","timestamp":1782723799000},"page":"1590-1603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inflammatory immune modulators of AML lung infiltration and respiratory failure"],"prefix":"10.1038","volume":"27","author":[{"given":"Varvara","family":"Paraskevopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Casado-Pelaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Grases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafa","family":"Al-Santli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Balandr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rashidfarrokhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9710-5567","authenticated-orcid":false,"given":"Stephen T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6452-301X","authenticated-orcid":false,"given":"Konstantinos","family":"Ntatsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4591-8150","authenticated-orcid":false,"given":"Tejas","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8325-971X","authenticated-orcid":false,"given":"Xufeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deedra","family":"Nicolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Escobosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7900-4239","authenticated-orcid":false,"given":"Eduard","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-9504","authenticated-orcid":false,"given":"Jennifer J.","family":"Trowbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9328-3817","authenticated-orcid":false,"given":"Kamal M.","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2251-1624","authenticated-orcid":false,"given":"Thales","family":"Papagiannakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-5249","authenticated-orcid":false,"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Loghavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7512-8477","authenticated-orcid":false,"given":"Aris","family":"Tsirigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kathrin","family":"Eisfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-6093","authenticated-orcid":false,"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-1035","authenticated-orcid":false,"given":"Iannis","family":"Aifantis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2582_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","volume":"12","author":"MJ Hayat","year":"2007","unstructured":"Hayat, M. J., Howlader, N., Reichman, M. E. & Edwards, B. K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12, 20\u201337 (2007).","journal-title":"Oncologist"},{"key":"2582_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/ajh.24246","volume":"91","author":"H Kantarjian","year":"2016","unstructured":"Kantarjian, H. Acute myeloid leukemia\u2013major progress over four decades and glimpses into the future. Am. J. Hematol. 91, 131\u2013145 (2016).","journal-title":"Am. J. Hematol."},{"key":"2582_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06810-7","volume":"15","author":"GO Nwosu","year":"2024","unstructured":"Nwosu, G. O., Ross, D. M., Powell, J. A. & Pitson, S. M. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia. Cell Death Dis. 15, 413 (2024).","journal-title":"Cell Death Dis."},{"key":"2582_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1378\/chest.98.5.1233","volume":"98","author":"FL Hildebrand Jr.","year":"1990","unstructured":"Hildebrand, F. L. Jr., Rosenow, E. C. III., Habermann, T. M. & Tazelaar, H. D. Pulmonary complications of leukemia. Chest 98, 1233\u20131239 (1990).","journal-title":"Chest"},{"key":"2582_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1164\/rccm.200206-554OC","volume":"167","author":"E Azoulay","year":"2003","unstructured":"Azoulay, E. et al. Acute monocytic leukemia presenting as acute respiratory failure. Am. J. Respir. Crit. Care Med. 167, 1329\u20131333 (2003).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2582_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1378\/chest.97.3.674","volume":"97","author":"R Kovalski","year":"1990","unstructured":"Kovalski, R., Hansen-Flaschen, J., Lodato, R. F. & Pietra, G. G. Localized leukemic pulmonary infiltrates. Diagnosis by bronchoscopy and resolution with therapy. Chest 97, 674\u2013678 (1990).","journal-title":"Chest"},{"key":"2582_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/1097-0142(196606)19:6<781::AID-CNCR2820190607>3.0.CO;2-U","volume":"19","author":"GP Bodey","year":"1966","unstructured":"Bodey, G. P., Powell, R. D. Jr., Hersh, E. M., Yeterian, A. & Freireich, E. J. Pulmonary complications of acute leukemia. Cancer 19, 781\u2013793 (1966).","journal-title":"Cancer"},{"key":"2582_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","volume":"36","author":"S Tettamanti","year":"2022","unstructured":"Tettamanti, S., Pievani, A., Biondi, A., Dotti, G. & Serafini, M. Catch me if you can: how AML and its niche escape immunotherapy. Leukemia 36, 13\u201322 (2022).","journal-title":"Leukemia"},{"key":"2582_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","volume":"177","author":"N Baryawno","year":"2019","unstructured":"Baryawno, N. et al. A cellular taxonomy of the bone marrow stroma in homeostasis and leukemia. Cell 177, 1915\u20131932 e1916 (2019).","journal-title":"Cell"},{"key":"2582_CR10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","volume":"176","author":"P van Galen","year":"2019","unstructured":"van Galen, P. et al. Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity. Cell 176, 1265\u20131281 e1224 (2019).","journal-title":"Cell"},{"key":"2582_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry, A. et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat. Cancer 4, 27\u201342 (2023).","journal-title":"Nat. Cancer"},{"key":"2582_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1158\/2159-8290.CD-20-0318","volume":"11","author":"H Ye","year":"2021","unstructured":"Ye, H. et al. The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG. Cancer Discov. 11, 500\u2013519 (2021).","journal-title":"Cancer Discov."},{"key":"2582_CR13","doi-asserted-by":"publisher","first-page":"e20220953","DOI":"10.1084\/jem.20220953","volume":"220","author":"L Sandhow","year":"2023","unstructured":"Sandhow, L. et al. Skin mesenchymal niches maintain and protect AML-initiating stem cells. J. Exp. Med. 220, e20220953 (2023).","journal-title":"J. Exp. Med."},{"key":"2582_CR14","volume":"2014","author":"D Vasilatou","year":"2014","unstructured":"Vasilatou, D. et al. CNS involvement in AML patient treated with 5-azacytidine. Case Rep. Hematol. 2014, 937203 (2014).","journal-title":"Case Rep. Hematol."},{"key":"2582_CR15","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41586-020-2922-4","volume":"587","author":"KJ Travaglini","year":"2020","unstructured":"Travaglini, K. J. et al. A molecular cell atlas of the human lung from single-cell RNA sequencing. Nature 587, 619\u2013625 (2020).","journal-title":"Nature"},{"key":"2582_CR16","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334 e1310 (2019).","journal-title":"Immunity"},{"key":"2582_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-021-03569-1","volume":"595","author":"JC Melms","year":"2021","unstructured":"Melms, J. C. et al. A molecular single-cell lung atlas of lethal COVID-19. Nature 595, 114\u2013119 (2021).","journal-title":"Nature"},{"key":"2582_CR18","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1017\/S1462399408000719","volume":"10","author":"RY Yang","year":"2008","unstructured":"Yang, R. Y., Rabinovich, G. A. & Liu, F. T. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med. 10, e17 (2008).","journal-title":"Expert Rev. Mol. Med."},{"key":"2582_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1378\/chest.87.2.259","volume":"87","author":"GA Rossi","year":"1985","unstructured":"Rossi, G. A., Balbi, B., Risso, M., Repetto, M. & Ravazzoni, C. Acute myelomonocytic leukemia. Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest 87, 259\u2013260 (1985).","journal-title":"Chest"},{"key":"2582_CR20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2017.08.001","volume":"32","author":"D Passaro","year":"2017","unstructured":"Passaro, D. et al. Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia. Cancer Cell 32, 324\u2013341 e326 (2017).","journal-title":"Cancer Cell"},{"key":"2582_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.21037\/atm.2017.06.51","volume":"5","author":"M Umbrello","year":"2017","unstructured":"Umbrello, M., Marino, A. & Chiumello, D. Tidal volume in acute respiratory distress syndrome: how best to select it. Ann. Transl. Med. 5, 287 (2017).","journal-title":"Ann. Transl. Med."},{"key":"2582_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-020-2822-7","volume":"586","author":"A Gillich","year":"2020","unstructured":"Gillich, A. et al. Capillary cell-type specialization in the alveolus. Nature 586, 785\u2013789 (2020).","journal-title":"Nature"},{"key":"2582_CR23","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-21-3594","volume":"28","author":"G Corradi","year":"2022","unstructured":"Corradi, G. et al. Release of IFN\u03b3 by acute myeloid leukemia cells remodels bone marrow immune microenvironment by inducing regulatory T Cells. Clin. Cancer Res. 28, 3141\u20133155 (2022).","journal-title":"Clin. Cancer Res."},{"key":"2582_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","volume":"607","author":"C Hong","year":"2022","unstructured":"Hong, C. et al. cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers. Nature 607, 366\u2013373 (2022).","journal-title":"Nature"},{"key":"2582_CR25","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/2159-8290.CD-21-1146","volume":"12","author":"A Yeaton","year":"2022","unstructured":"Yeaton, A. et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discov. 12, 2392\u20132413 (2022).","journal-title":"Cancer Discov"},{"key":"2582_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"J Villar","year":"2020","unstructured":"Villar, J. et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med. 8, 267\u2013276 (2020).","journal-title":"Lancet Respir. Med."},{"key":"2582_CR27","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1055\/s-2006-939517","volume":"27","author":"J Allen","year":"2006","unstructured":"Allen, J. Acute eosinophilic pneumonia. Semin. Respir. Crit. Care Med. 27, 142\u2013147 (2006).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"2582_CR28","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1183\/09031936.00057711","volume":"39","author":"E Azoulay","year":"2012","unstructured":"Azoulay, E. et al. Dexamethasone in patients with acute lung injury from acute monocytic leukaemia. Eur. Respir. J. 39, 648\u2013653 (2012).","journal-title":"Eur. Respir. J."},{"key":"2582_CR29","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"2582_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-immunol-042617-053119","volume":"37","author":"PB Narasimhan","year":"2019","unstructured":"Narasimhan, P. B., Marcovecchio, P., Hamers, A. A. J. & Hedrick, C. C. Nonclassical monocytes in health and disease. Annu. Rev. Immunol. 37, 439\u2013456 (2019).","journal-title":"Annu. Rev. Immunol"},{"key":"2582_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13764-3","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang, J. et al. Role of CD47 in tumor immunity: a potential target for combination therapy. Sci Rep. 12, 9803 (2022).","journal-title":"Sci Rep."},{"key":"2582_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41586-021-03626-9","volume":"595","author":"KO Dixon","year":"2021","unstructured":"Dixon, K. O. et al. TIM-3 restrains anti-tumour immunity by regulating inflammasome activation. Nature 595, 101\u2013106 (2021).","journal-title":"Nature"},{"key":"2582_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-34154-3","volume":"13","author":"S Chen","year":"2023","unstructured":"Chen, S., Zhang, S., Chen, S. & Ma, F. The prognostic value and immunological role of CD44 in pan-cancer study. Sci Rep. 13, 7011 (2023).","journal-title":"Sci Rep."},{"key":"2582_CR34","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1158\/1078-0432.CCR-23-0276","volume":"29","author":"J Mascarenhas","year":"2023","unstructured":"Mascarenhas, J. et al. A phase Ib trial of AVID200, a TGF\u03b2 1\/3 Trap, in patients with myelofibrosis. Clin. Cancer Res. 29, 3622\u20133632 (2023).","journal-title":"Clin. Cancer Res."},{"key":"2582_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54290-2","volume":"15","author":"JJ Rodriguez-Sevilla","year":"2024","unstructured":"Rodriguez-Sevilla, J. J. et al. The IL-1\u03b2 inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial. Nat. Commun. 15, 9840 (2024).","journal-title":"Nat. Commun."},{"key":"2582_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1533335","volume":"16","author":"F Sheng","year":"2025","unstructured":"Sheng, F. et al. IL-33\/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential. Front. Immunol. 16, 1533335 (2025).","journal-title":"Front. Immunol."},{"key":"2582_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.7150\/ijbs.79852","volume":"19","author":"S Zheng","year":"2023","unstructured":"Zheng, S. et al. Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity. Int. J. Biol. Sci. 19, 981\u2013993 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"2582_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41420-023-01515-w","volume":"9","author":"G Choukrani","year":"2023","unstructured":"Choukrani, G. et al. Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance. Cell Death Discov. 9, 228 (2023).","journal-title":"Cell Death Discov"},{"key":"2582_CR39","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","volume":"10","author":"Y Lv","year":"2023","unstructured":"Lv, Y., Ma, X., Ma, Y., Du, Y. & Feng, J. A new emerging target in cancer immunotherapy: galectin-9 (LGALS9). Genes Dis. 10, 2366\u20132382 (2023).","journal-title":"Genes Dis."},{"key":"2582_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106409","volume":"96","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. IL-33\/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia. Leuk. Res. 96, 106409 (2020).","journal-title":"Leuk. Res."},{"key":"2582_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.add7705","volume":"16","author":"P Naef","year":"2023","unstructured":"Naef, P. et al. IL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways. Sci. Signal. 16, eadd7705 (2023).","journal-title":"Sci. Signal."},{"key":"2582_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61567-7","volume":"16","author":"D Fu","year":"2025","unstructured":"Fu, D. et al. Dual targeting of tumoral cells and immune microenvironment by blocking the IL-33\/IL1RL1 pathway. Nat. Commun. 16, 6369 (2025).","journal-title":"Nat. Commun."},{"key":"2582_CR43","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47, W556\u2013W560 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2582_CR44","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/eji.201343335","volume":"43","author":"F Gieseke","year":"2013","unstructured":"Gieseke, F. et al. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation. Eur. J. Immunol. 43, 2741\u20132749 (2013).","journal-title":"Eur. J. Immunol."},{"key":"2582_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42327-x","volume":"14","author":"I Dolgalev","year":"2023","unstructured":"Dolgalev, I. et al. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma. Nat. Commun. 14, 6764 (2023).","journal-title":"Nat. Commun."},{"key":"2582_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21099-2","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang, R. et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat. Commun. 12, 832 (2021).","journal-title":"Nat. Commun."},{"key":"2582_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61647-8","volume":"16","author":"H Jiang","year":"2025","unstructured":"Jiang, H. et al. ST2\/IL-33 axis blockade inhibits regulatory T cell cytotoxicity towards CD8 T cells in the leukemic niche. Nat. Commun. 16, 6580 (2025).","journal-title":"Nat. Commun."},{"key":"2582_CR48","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","volume":"385","author":"ME Wechsler","year":"2021","unstructured":"Wechsler, M. E. et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma. N. Engl. J. Med. 385, 1656\u20131668 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2582_CR49","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2582_CR50","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2024-209848","volume":"144","author":"A Filipovic","year":"2024","unstructured":"Filipovic, A. et al. A phase I dose escalation and expansion trial of Lyt-200 (a first-in-class anti-galectin-9 antibody) alone and in combination with venetoclax\/HMA in relapsed\/refractory AML\/MDS. Blood 144, 1499 (2024).","journal-title":"Blood"},{"key":"2582_CR51","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/dvdy.20643","volume":"235","author":"JA Alva","year":"2006","unstructured":"Alva, J. A. et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235, 759\u2013767 (2006).","journal-title":"Dev. Dyn."},{"key":"2582_CR52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"2582_CR53","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41375-018-0368-6","volume":"33","author":"MA Loberg","year":"2019","unstructured":"Loberg, M. A. et al. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia 33, 1635\u20131649 (2019).","journal-title":"Leukemia"},{"key":"2582_CR54","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/2159-8290.CD-22-0601","volume":"13","author":"C Glytsou","year":"2023","unstructured":"Glytsou, C. et al. Mitophagy promotes resistance to BH3 mimetics in acute myeloid leukemia. Cancer Discov. 13, 1656\u20131677 (2023).","journal-title":"Cancer Discov."},{"key":"2582_CR55","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/2159-8290.CD-18-1391","volume":"9","author":"E Loizou","year":"2019","unstructured":"Loizou, E. et al. A gain-of-function p53-mutant oncogene promotes cell fate plasticity and myeloid leukemia through the pluripotency factor FOXH1. Cancer Discov. 9, 962\u2013979 (2019).","journal-title":"Cancer Discov."},{"key":"2582_CR56","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","volume":"166","author":"D Daley","year":"2016","unstructured":"Daley, D. et al. \u03b3\u03b4 T cells support pancreatic oncogenesis by restraining \u03b1\u03b2 T cell activation. Cell 166, 1485\u20131499 e1415 (2016).","journal-title":"Cell"},{"key":"2582_CR57","doi-asserted-by":"publisher","first-page":"e20211906","DOI":"10.1084\/jem.20211906","volume":"219","author":"M Quattrocelli","year":"2022","unstructured":"Quattrocelli, M. et al. Intermittent prednisone treatment in mice promotes exercise tolerance in obesity through adiponectin. J. Exp. Med. 219, e20211906 (2022).","journal-title":"J. Exp. Med."},{"key":"2582_CR58","doi-asserted-by":"publisher","first-page":"eaax8756","DOI":"10.1126\/sciimmunol.aax8756","volume":"5","author":"BB Ural","year":"2020","unstructured":"Ural, B. B. et al. Identification of a nerve-associated, lung-resident interstitial macrophage subset with distinct localization and immunoregulatory properties. Sci. Immunol. 5, eaax8756 (2020).","journal-title":"Sci. Immunol."},{"key":"2582_CR59","doi-asserted-by":"publisher","unstructured":"Dolgalev, I. Seq-N-Slide. Zenodo https:\/\/doi.org\/10.5281\/zenodo.5550459 (2025).","DOI":"10.5281\/zenodo.5550459"},{"key":"2582_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2582_CR61","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"2582_CR62","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"2582_CR63","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie, Z. et al. Gene set knowledge discovery with Enrichr. Curr. Protoc. 1, e90 (2021).","journal-title":"Curr. Protoc."},{"key":"2582_CR64","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat. Protoc. 15, 1484\u20131506 (2020).","journal-title":"Nat. Protoc."},{"key":"2582_CR65","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"2582_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s43018-022-00356-3","volume":"3","author":"T Chu","year":"2022","unstructured":"Chu, T., Wang, Z., Pe\u2019er, D. & Danko, C. G. Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. Nat. Cancer 3, 505\u2013517 (2022).","journal-title":"Nat. Cancer"},{"key":"2582_CR67","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2582_CR68","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41587-021-00830-w","volume":"40","author":"DM Cable","year":"2022","unstructured":"Cable, D. M. et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat. Biotechnol. 40, 517\u2013526 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2582_CR69","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"29","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 29, 1563\u20131577 (2023).","journal-title":"Nat. Med."},{"key":"2582_CR70","doi-asserted-by":"publisher","unstructured":"Paraskevopoulou, V. et al. Processed Seurat objects for AML lung infiltration and respiratory failure. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.20274428 (2026).","DOI":"10.5281\/zenodo.20274428"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02582-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02582-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:09:33Z","timestamp":1785517773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02582-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02582-8","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.T. is a scientific advisor to Intelligencia AI. A.-K.E. receives royalties for advisory board participation from Syndax, Servier, Daiichi Sankyo, Foundation Medicine, royalties from Astellas, VJ HemeOnc, MD Education and DAVA Oncology; her spouse is employed at Karyopharm Therapeutics. S.L. reports personal fees for consultation and advisory board participation from Abbvie, AlphaSights, American Society of Clinical Oncology, Aptitude Health, Arima Diagnostics, BluePrint Medicine, Bristol Myers Squibb, Caris Diagnostics, Celgene Corporation, Cogent Biosciences, Daiichi Sankyo, Gerson Lehrman Group, Genentech, Janssen Pharmaceuticals, Kura Oncology, MD Education, OncLive, Physicians\u2019 Education Resource, Recordati, Servier, Stemline Therapeutics, QIAGEN, Syndax, Springer, Tempus AI and VJ HemeOnc, and research grants from Atellas and Amgen outside of the submitted work. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}